This topic contains a solution. Click here to go to the answer

Author Question: The heart of a behavior support plan lies in the extent to which the plan is a. Based on ... (Read 179 times)

jayhills49

  • Hero Member
  • *****
  • Posts: 559
The heart of a behavior support plan lies in the extent to which the plan is
 
  a. Based on functional assessment results
  b. Consistent with fundamental principles of behavior
  c. A good contextual fit with the values, resources, and skills of all people in the setting
  d. All of the above
  e. None of the above

Question 2

An effective written plan provides a format for
 
  a. Modifying the thought patterns of the individual with problem behavior
  b. Modifying support procedures in response to ongoing changes in the target individual's behavior and context
  c. Modifying the inner states within the individual that need to be changed
  d. All of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

perkiness

  • Sr. Member
  • ****
  • Posts: 348
Answer to Question 1

d

Answer to Question 2

b




jayhills49

  • Member
  • Posts: 559
Reply 2 on: Jun 20, 2018
Gracias!


EAN94

  • Member
  • Posts: 307
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library